These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31846493)

  • 21. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.
    García-León JA; Pinto-Medel MJ; García-Trujillo L; López-Gómez C; Oliver-Martos B; Prat-Arrojo I; Marín-Bañasco C; Suardíaz-García M; Maldonado-Sanchez R; Fernández-Fernández O; Leyva-Fernández L
    Mol Immunol; 2011 Sep; 48(15-16):1896-902. PubMed ID: 21665278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis.
    Hanson AL; ; Vukcevic D; Leslie S; Harris J; Lê Cao KA; Kenna TJ; Brown MA
    PLoS Genet; 2020 Aug; 16(8):e1008906. PubMed ID: 32804949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
    PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis.
    Marastoni D; Magliozzi R; Bolzan A; Pisani AI; Rossi S; Crescenzo F; Montemezzi S; Pizzini FB; Calabrese M
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34588298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis.
    Mahmoudi M; Jamshidi AR; Karami J; Mohseni A; Amirzargar AA; Farhadi E; Ahmadzadeh N; Nicknam MH
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):27-38. PubMed ID: 26996109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND THEIR HLA-C LIGANDS IN HASHIMOTO THYROIDITIS IN A CHINESE POPULATION.
    Li JT; Guo C; Li ML; Wei YQ; Hou YF; Jiao YL; Zhao YR; Sun H; Xu J; Cao MF; Feng L; Yu GN; Gao L; Liu YQ; Zhang BC; Zhao JJ; Zhang HQ
    Endocr Pract; 2016 Aug; 22(8):935-40. PubMed ID: 27042744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome.
    La Manna G; Corsini S; Iannelli S; Cappuccilli ML; Comai G; Iorio M; Todeschini P; Carretta E; Scolari MP; Bontadini A; Stefoni S
    Ann Transplant; 2013 Nov; 18():611-21. PubMed ID: 24220609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of Genes for Killer Cell Immunoglobulin-like Receptors and Their Human Leukocyte Antigen-A/B/C Ligands with Abdominal Aortic Aneurysm.
    Dubis J; Niepiekło-Miniewska W; Jędruchniewicz N; Sobczyński M; Witkiewicz W; Zapotoczny N; Kuśnierczyk P
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil activity in serum as a biomarker for multiple sclerosis.
    Holm Nielsen S; Karsdal M; Bay-Jensen AC
    Mult Scler Relat Disord; 2023 Nov; 79():105005. PubMed ID: 37714096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study.
    Goedert JJ; Martin MP; Vitale F; Lauria C; Whitby D; Qi Y; Gao X; Carrington M
    J Infect Dis; 2016 Feb; 213(3):432-8. PubMed ID: 26268853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human leucocyte antigen but not KIR alleles and haplotypes associated with chronic HCV infection in a Chinese Han population.
    Li Q; Liu S; Zhang S; Liu C; Sun M; Li C; Zhang X; Chen J; Yao Y; Shi L
    Int J Immunogenet; 2019 Aug; 46(4):263-273. PubMed ID: 30932338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.
    Ottervald J; Franzén B; Nilsson K; Andersson LI; Khademi M; Eriksson B; Kjellström S; Marko-Varga G; Végvári A; Harris RA; Laurell T; Miliotis T; Matusevicius D; Salter H; Ferm M; Olsson T
    J Proteomics; 2010 Apr; 73(6):1117-32. PubMed ID: 20093204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
    Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association between KIR and HLA-C type and susceptibility to idiopathic bronchiectasis.
    McDonnell MJ; Anwar GA; Rutherford RM; De Soyza A; Worthy S; Corris PA; Lordan JL; Bourke S; Afolabi G; Ward C; Middleton P; Middleton D
    Respir Med; 2014 Aug; 108(8):1127-33. PubMed ID: 24986480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
    Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
    Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone.
    Boylan MT; Crockard AD; McDonnell GV; Armstrong MA; Hawkins SA
    J Neurol Sci; 1999 Aug; 167(2):79-89. PubMed ID: 10521545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.
    Kizlaitienė R; Kaubrys G; Giedraitienė N; Ramanauskas N; Dementavičienė J
    Med Sci Monit; 2017 Feb; 23():588-597. PubMed ID: 28145395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types.
    Greer JM; Trifilieff E; Pender MP
    Front Immunol; 2020; 11():1891. PubMed ID: 32973782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.